GNH USA

Europe — EMA

Micofenolato De Mofetilo Tecnigen

GNH USA supplies Micofenolato De Mofetilo Tecnigen (Mycophenolate Mofetil), an antimetabolite immunosuppressant for organ transplant rejection and lupus

Mycophenolate Mofetil

Request sourcing

1
Pack/s

What is Mycophenolate Mofetil?

Mycophenolate Mofetil, the active ingredient in Micofenolato De Mofetilo Tecnigen, is an antimetabolite immunosuppressant presented as an oral formulation for oral use. It is employed to prevent acute rejection in organ transplantation and to treat certain autoimmune kidney disorders.

GNH USA supplies Micofenolato De Mofetilo Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

What is Mycophenolate Mofetil used for?

Mycophenolate Mofetil acts on the immune system to reduce lymphocyte proliferation, making it useful in several transplant‑related and autoimmune conditions. - Kidney transplantation: helps prevent acute graft rejection and supports long‑term graft survival. - Heart transplantation: reduces the risk of early and late rejection episodes. - Liver transplantation: maintains graft function by suppressing immune activation. - Lupus nephritis: diminishes renal inflammation and proteinuria in systemic lupus erythematosus. - Autoimmune disorders: provides immunosuppression for selected severe autoimmune diseases.

What are the side effects of Mycophenolate Mofetil?

Adverse reactions may range from mild to severe and should be monitored throughout therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, sometimes leading to dehydration. - Abdominal pain: cramping or discomfort in the stomach area. - Headache: transient mild to moderate pain. - Infections: increased susceptibility to bacterial, viral, or fungal infections. - Leukopenia: reduced white blood cell count, raising infection risk.

Serious or Rare Side Effects: - Severe neutropenia: markedly low neutrophil levels, potentially life‑threatening. - Opportunistic infections: such as Pneumocystis jirovecii pneumonia. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Malignancy: increased long‑term risk of certain cancers. - Progressive multifocal leukoencephalopathy (PML): rare demyelinating disease. - Gastrointestinal perforation: rare but serious abdominal emergency.

What precautions apply to Mycophenolate Mofetil?

Patients receiving Mycophenolate Mofetil require careful monitoring and specific safety measures. - Blood counts: monitor complete blood count regularly to detect leukopenia or neutropenia. - Renal function: assess serum creatinine and glomerular filtration rate periodically. - Pregnancy: avoid use during pregnancy (Category D) and ensure effective contraception. - Breastfeeding: contraindicated; do not breastfeed while on therapy. - Hepatic impairment: dose adjustment may be needed in patients with liver dysfunction. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

What does Mycophenolate Mofetil interact with?

Mycophenolate Mofetil can interact with several drugs, altering efficacy or safety.

Major Interactions (Avoid): - Rifampin or other strong CYP3A4 inducers: may markedly reduce drug exposure. - Live vaccines: increased risk of vaccine‑derived infection. - Cholestyramine or other bile‑acid sequestrants: can decrease absorption.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone‑marrow suppression; monitor blood counts. - Calcineurin inhibitors (tacrolimus, cyclosporine): may increase mycophenolate levels; adjust dose as needed. - ACE inhibitors or ARBs: combined use may worsen renal function; monitor creatinine. - NSAIDs: concurrent use can impair renal perfusion; watch for kidney injury.

Frequently asked questions

What conditions is Micofenolato De Mofetilo Tecnigen used for?+
Micofenolato De Mofetilo Tecnigen, containing Mycophenolate Mofetil, is prescribed to prevent acute rejection in kidney, heart and liver transplants, to maintain long‑term graft survival, and to treat lupus nephritis and selected severe autoimmune disorders.
How does Mycophenolate Mofetil work in the body?+
Mycophenolate Mofetil is converted to mycophenolic acid, which selectively blocks the enzyme inosine monophosphate dehydrogenase (IMPDH). This inhibition reduces guanosine nucleotide synthesis, limiting the proliferation of T‑ and B‑lymphocytes and thereby dampening the immune response.
What is the usual dose of Micofenolato De Mofetilo Tecnigen?+
The dosage of Micofenolato De Mofetilo Tecnigen is individualized. The prescribing clinician determines the appropriate amount based on the patient’s transplant type, renal function, and overall clinical condition. Patients should follow the exact regimen provided by their healthcare professional.
Is Micofenolato De Mofetilo Tecnigen safe during pregnancy or breastfeeding?+
Mycophenolate Mofetil is classified as Pregnancy Category D, indicating evidence of fetal risk. It should not be used during pregnancy, and effective contraception is required. The drug is also contraindicated while breastfeeding because it can be excreted in milk and affect the infant.
How do I order Micofenolato De Mofetilo Tecnigen from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Micofenolato De Mofetilo Tecnigen compare with other immunosuppressants?+
Compared with calcineurin inhibitors such as tacrolimus, Mycophenolate Mofetil offers a different mechanism—targeting lymphocyte proliferation rather than cytokine production. It is often used in combination regimens to provide synergistic immunosuppression while allowing lower doses of each agent, potentially reducing toxicity.
What are the recommended storage conditions for Micofenolato De Mofetilo Tecnigen?+
Store the product below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not expose the tablets or capsules to excessive heat or humidity, and keep them out of reach of children.
How is Micofenolato De Mofetilo Tecnigen administered?+
The medication is taken orally, usually with food or a glass of water to lessen gastrointestinal irritation. The exact timing and frequency are set by the prescribing physician, who may adjust the schedule based on therapeutic monitoring.
What are the most serious risks associated with Micofenolato De Mofetilo Tecnigen?+
Serious risks include severe neutropenia, opportunistic infections (e.g., Pneumocystis jirovecii pneumonia), hepatic toxicity, and an increased long‑term risk of certain malignancies. Patients should be monitored regularly for blood‑count changes, liver‑function abnormalities and signs of infection.
Who should not use Micofenolato De Mofetilo Tecnigen?+
The drug is contraindicated in patients with known hypersensitivity to Mycophenolate Mofetil or any excipients, in pregnant women, and in individuals with uncontrolled infections. Caution is also advised for patients with severe hepatic impairment or existing bone‑marrow suppression.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mycophenolate Mofetil
Route
Oral Use
Manufacturer
Tecnimede España Ind. Fca., S.A.
Origin
EU

Related products